Competitive Technologies, Inc. (OTCQX: CTTC) Distributor of Calmare--a non-invasive and non-narcotic chronic pain management medical device with FDA 510K Marketing Allowance
TV News Report on Calmare (June 7, 2013)
NEAR TERM CATALYST
----CTTC to Exhibit Calmare at ASCO in May
---- Information on Possible Abstracts or Entries in Poster Sessions Permitted after April 21 (usually companies issue a Press Release after public posting on ASCO website)
American Society of Clinical Oncology
2014 Annual Meeting
Competitive Technologies, Inc., will be presenting the Calmare® Pain Therapy Medical Device at the ASCO 2014 Annual Meeting.
The American Society of Clinical Oncology (ASCO) 2014 Annual Meeting, held at McCormick place, May 30th - June 3rd, 2014 in Chicago, Illinois, is the premier educational and scientific event in the oncology community.
The ASCO Annual Meeting provides a forum for oncology professionals from a diverse range of specialties to explore the most advanced treatments, technologies, products, and services in cancer care. Expert speakers will lead attendees through the latest issues, treatments, techniques and medical solutions while addressing the unique challenges presented to the oncological community.
Calmare® is a non-invasive treatment for drug-resistant chronic neuropathic and cancer pain.
Visit Competitive Technologies in booth 5072
Scrambler Therapy/Calmare is covered under certain health plans.
More insurance plans are adding coverage daily. Please call David Palmieri of Calmare Pain Relief Solutions at (800) 899-0574 for the most up to date list of insurance companies covering this treatment.
The following companies offer plans that cover the Calmare treatment. Most New York state no-fault insurance companies do cover this procedure.
Blue Cross Blue Shield
The Empire Plan
Esurance Insurance Company
21 Century Insurance
Auto One Insurance
State Farm Insurance
New York Central Mutual
State Insurance Fund
TV News Report Calmare technology and patient testimonial (2011) (http://www.ksl.com/?nid=148&sid=16580318).
Deseret News article: (http://www.deseretnews.com/article/705388446/Device-used-by-southern-Utah-doctor-is-helping-people-live-a-life-without-constant-pain.html) highlighted the success Dr. Robert Chalmers of Utah had in treatment of a teenager who had suffered from severe pain from a nerve disorder called reflex neurovascular dystrophy, or RND, for nearly two years.
CTTC in summary
Calmare Specific Treatment Indications for Chronic Pain Include –
- Calmare is a medical device that treats Chronic Pain Patients, FDA and CE approved
- 116 million people experience Chronic Pain in the US.
- There are independently initiated clinical trials at the Mayo, University of Wisconsin, Massey Cancer Center and Johns Hopkins to validate the significant results that have been observed.
- 194 systems have been sold worldwide with 16 currently in place with the VA and US Navy Hospitals.
- 450 Calmare Units in inventory
·Chronic Neuropathic Pain
- Chemotherapy Induced Peripheral Neuropathy (CIPN)
- Intractable Cancer Pain
- Failed Back Surgery Syndrome
- Sciatic and Lumbar Pain
- Post Herpetic Neuralgia
- Brachial Plexus Pain
- Low Back Pain